MCP
ZBH icon

Meridiem Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Meridiem Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55M Buy
+638,555
New +$56M 2.46% 9
2025
Q2 		– Sell
-237,950
Closed -$26.9M – 99
2025
Q1 		$26.9M Buy
237,950
+129,018
+118% +$13.8M 2.81% 13
2024
Q4 		$11.5M Buy
+108,932
New +$11.7M 1.01% 39

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meridiem Capital Partners's ZBH Position: Q2 2026 in Review

Meridiem Capital Partners opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 638,555 shares worth $55M. The stake represents 2.46% of the portfolio and ranks #9 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in ZBH as recently as Q1 2025.

Meridiem Capital Partners first reported a position in ZBH in Q4 2024 and has held it in 3 quarters since. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Meridiem Capital Partners held 638,555 shares of Zimmer Biomet worth $55M as of Q2 2026.
  • Zimmer Biomet was a new Meridiem Capital Partners position in Q2 2026.
  • Zimmer Biomet made up 2.46% of Meridiem Capital Partners's portfolio in Q2 2026, its #9 holding.
  • Meridiem Capital Partners first reported a position in Zimmer Biomet in Q4 2024 and has held it in 3 quarters since.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.